Pesquisas alternativas:
loss develop » locus develop (Expandir a Pesquisa), boys develop (Expandir a Pesquisa), less developed (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa)
drug loss » drug lots (Expandir a Pesquisa), drug cross (Expandir a Pesquisa), drug lists (Expandir a Pesquisa)
de devel » de deber (Expandir a Pesquisa), de devic (Expandir a Pesquisa), _ devel (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug deal (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
loss develop » locus develop (Expandir a Pesquisa), boys develop (Expandir a Pesquisa), less developed (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
devel ther » novel ther (Expandir a Pesquisa), level theory (Expandir a Pesquisa)
drug loss » drug lots (Expandir a Pesquisa), drug cross (Expandir a Pesquisa), drug lists (Expandir a Pesquisa)
de devel » de deber (Expandir a Pesquisa), de devic (Expandir a Pesquisa), _ devel (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug deal (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
201
Por Brilliant, Murray H., Vaziri, Kamyar, Connor, Thomas B., Schwartz, Stephen G., Carroll, Joseph J., McCarty, Catherine A., Schrodi, Steven J., Hebbring, Scott J., Kishor, Krishna S., Flynn, Harry W., Moshfeghi, Andrew A., Moshfeghi, Darius M., Fini, M. Elizabeth, McKay, Brian S.
Publicado no Am J Med (2015)
“...BACKGROUND: Age-related macular degeneration (AMD) is a leading cause of visual loss among...”Publicado no Am J Med (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
202
203
Por Ngo, Huy X., Shrestha, Sanjib K., Green, Keith D., Garneau-Tsodikova, Sylvie
Publicado no Bioorg Med Chem (2016)
“...) and evaluated them against a panel of drug sensitive and drug resistant S. aureus and non-S. aureus strains...”Publicado no Bioorg Med Chem (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
204
“... them viable and attractive drug targets. The aim of this review was to evaluate the role of innate...”
Obter o texto integral
Obter o texto integral
Artigo
205
“... of autoinflammatory diseases making them viable and attractive drug targets. The aim of this review was to evaluate...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
206
“... hypoglycemic drug, possesses antioxidant effects. The aim of this paper is to investigate the protective...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
207
Por Sinha, R P
Publicado em 1986
“... for 18 to 22 h. These drug-resistant mutants showed no loss of resistance even after 6 months...”Publicado em 1986
Obter o texto integral
Obter o texto integral
Artigo
208
Por Richman, D D, Havlir, D, Corbeil, J, Looney, D, Ignacio, C, Spector, S A, Sullivan, J, Cheeseman, S, Barringer, K, Pauletti, D
Publicado em 1994
“... was associated with the loss of antiviral drug activity as measured by CD4 lymphocyte counts and levels of HIV p...”Publicado em 1994
Obter o texto integral
Obter o texto integral
Artigo
209
Por Ahrén, Bo
Publicado em 2013
“..., or drug or alcohol consumption may also contribute. Specific risk factors for development of hypoglycemia...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
210
Por Mathieu, Véronique, Chantôme, Aurélie, Lefranc, Florence, Cimmino, Alessio, Miklos, Walter, Paulitschke, Verena, Mohr, Thomas, Maddau, Lucia, Kornienko, Alexander, Berger, Walter, Vandier, Christophe, Evidente, Antonio, Delpire, Eric, Kiss, Robert
Publicado no Cell Mol Life Sci (2015)
“... shrinkage related to the loss of intracellular Cl(−) and the decreased HCO(3) (−) concentration...”Publicado no Cell Mol Life Sci (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
211
“...Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the loss...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
212
Por Neutzsky-Wulff, Anita V, Andreassen, Kim V, Hjuler, Sara T, Feigh, Michael, Bay-Jensen, Anne-Christine, Zheng, Qinlong, Henriksen, Kim, Karsdal, Morten A
Publicado em 2012
“... biomarkers reflecting β-cell health status may also assist development of new drugs for T2DM and aid...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
213
Por Francisco J Arjona, Jeroen H F de Baaij, Karl P Schlingmann, Anke L L Lameris, Erwin van Wijk, Gert Flik, Sabrina Regele, G Christoph Korenke, Birgit Neophytou, Stephan Rust, Nadine Reintjes, Martin Konrad, René J M Bindels, Joost G J Hoenderop
Publicado em 2014-04-01
“... for brain development, neurological functioning and Mg(2+) homeostasis. By establishing the loss-of-function...”Publicado em 2014-04-01
Obter o texto integral
Artigo
214
Por Arjona, Francisco J., de Baaij, Jeroen H. F., Schlingmann, Karl P., Lameris, Anke L. L., van Wijk, Erwin, Flik, Gert, Regele, Sabrina, Korenke, G. Christoph, Neophytou, Birgit, Rust, Stephan, Reintjes, Nadine, Konrad, Martin, Bindels, René J. M., Hoenderop, Joost G. J.
Publicado em 2014
“... for brain development, neurological functioning and Mg(2+) homeostasis. By establishing the loss-of-function...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
215
Por Housden, Benjamin E., Valvezan, Alexander J., Kelley, Colleen, Sopko, Richelle, Hu, Yanhui, Roesel, Charles, Lin, Shuailiang, Buckner, Michael, Tao, Rong, Yilmazel, Bahar, Mohr, Stephanie E., Manning, Brendan D., Perrimon, Norbert
Publicado no Sci Signal (2015)
“... cells with functional loss of this complex is therefore of clinical relevance to patients...”Publicado no Sci Signal (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
216
“...The life cycle of human immunodeficiency virus type 1 (HIV-1) is intricately related...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
217
Por Altman, Michael D., Ali, Akbar, Reddy, G. S. Kiran Kumar, Nalam, Madhavi N. L., Anjum, Saima Ghafoor, Cao, Hong, Chellappan, Sripriya, Kairys, Visvaldas, Fernandes, Miguel X., Gilson, Michael K., Schiffer, Celia A., Rana, Tariq M., Tidor, Bruce
Publicado em 2008
“... of drug-resistant HIV-1 protease variants, losing no more than 6–13 fold affinity relative to wild type...”Publicado em 2008
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
218
Por Mukherjee, Abhisek, Syeb, Kathleen, Concannon, John, Callegari, Keri, Soto, Claudio, Glicksman, Marcie A.
Publicado no PLoS One (2015)
“... therapeutic approaches under development focuses on inhibiting the misfolding and aggregation pathway. However...”Publicado no PLoS One (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
219
“...Glatiramer acetate (GA, Copaxone, Copolymer 1) is an approved drug for the treatment of multiple...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
220
Por Freeman, Jeffrey S.
Publicado em 2010
“...Progressive deterioration of β-cell function is a hallmark of type 2 diabetes mellitus (DM...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo